title: Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: N
authors.initials: N
authors.lastname: Fabre
authors.forename: O
authors.initials: O
authors.lastname: Blin
authors.forename: J M
authors.initials: JM
authors.lastname: Senard
authors.forename: O
authors.initials: O
authors.lastname: Rascol
authors.forename: A
authors.initials: A
authors.lastname: Rascol
mesh_terms: D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D010865:Pilot Projects; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D005473:Fluoxetine; D007980:Levodopa